// App-Quantinova.ai

3353 : Cancer stem cell markers (ALDH1 and CD133) expression could be associated with a poor prognosis in the patients with lung adenocarcinoma

Researchers

Presenter

  • Takeaki Miyata

Principal Investigators

  • Takashi Yoshimatsu

  • Atsushi Sekimura

  • Tetsuya So

  • Naohiro Nose

  • Tsunehiro Oyama

  • Hisao Nagaya

  • Akinobu Gotoh

Medical Centers

  • Hyogo College of Medicine, Nishinomiya-shi, Hyogo, Japan

  • Fukuoka-Wajiro Hospital, Fukuoka-City, Japan

  • Shin-Takeo Hospital, Takeo-City, Japan

  • Shin-Komonji Hospital, Kitakyusyu-City, Japan

  • Shin-Yukuhashi Hospital, Yukuhashi-City, Japan

  • Imamitsu Home Care Clinic, Kitakyusyu-City, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Aldehyde dehydrogenase 1

  • Prominin 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved